Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder

American Journal of Psychiatry

Volumn 158, Issue 9, 2001, Pages 1514-1516

  Strohle A ^a   Kellner, M ^a   Holsboer, F ^a   Wiedemann, K ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; ATRIAL NATRIURETIC FACTOR; TETRAGASTRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; PANIC; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOMATOLOGY; TRANQUILIZING ACTIVITY;

ADULT; ANTI-ANXIETY AGENTS; ATRIAL NATRIURETIC FACTOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PANIC DISORDER; PLACEBOS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; TETRAGASTRIN;

EID: 0034842369     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.9.1514     Document Type: Article

References (11)

1. Atrial natriuretic factor: A hormone produced by the heart
2. The natriuretic peptide system in the brain: Implications in the central control of cardiovascular and neuroendocrine functions
3. Possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic
4. Central and peripheral administration of atriopeptin is anxiolytic in rats
5. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder
6. Comparison of the panicogenic effects of cholecystokinin 30-33 and carbon dioxide in panic disorder
7. Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients
8. Measurement of lactate-induced panic and anxiety
9. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder
10. On the blood-brain barrier to peptides: Specific binding of atrial natriuretic peptide in vivo and in vitro
11. Autonomic reactivity and hormonal secretion in lactate-induced panic attacks